Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease

Thirunavukkarasu Velusamy1, Archana S Panneerselvam2, Meera Purushottam3

  • 1Department of Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India; DBT Ramalingaswami Re-Entry Fellowship Programme, Department of Biotechnology (DBT), New Delhi, India.

Insights

Antioxidants show promise in treating Huntington's disease (HD) by combating oxidative stress and promoting neurogenesis. Further research into their mechanisms could unlock new therapeutic strategies for neurodegenerative disorders.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms.
  • Oxidative stress and mitochondrial dysfunction in neurons, linked to CAG mutations in the HTT gene, are implicated in HD pathogenesis.
  • Adult neurogenesis, the brain's regenerative capacity, is crucial for cognitive functions and can be positively modulated by antioxidants.

Purpose of the Study:

  • To review current research on the therapeutic potential of antioxidants in managing Huntington's disease and other neurological disorders.
  • To explore the role of antioxidants in promoting adult neurogenesis and neuroprotection within the context of HD.
  • To advocate for new research directions investigating the mechanisms by which antioxidants enhance adult neurogenesis in HD.

Main Methods:

  • Comprehensive literature review of recent studies on antioxidants, Huntington's disease, and adult neurogenesis.
  • Analysis of existing data linking oxidative stress, neurodegeneration, and the regenerative potential of the brain.
  • Synthesis of findings to identify therapeutic strategies and research gaps.

Main Results:

  • Antioxidants show potential in mitigating free radical toxicity and oxidative stress associated with neurodegenerative diseases like HD.
  • Positive modulation of adult neurogenesis by antioxidants suggests a promising avenue for neuroprotection and functional recovery in HD.
  • Existing research indicates a supportive role for antioxidants in reducing HD severity through enhanced neurogenesis and neuroprotection.

Conclusions:

  • Antioxidants represent a promising therapeutic strategy for Huntington's disease, potentially by enhancing neuroprotection and promoting adult neurogenesis.
  • Further investigation into the precise mechanisms by which antioxidants influence adult neurogenesis in HD is warranted.
  • This review highlights the significant therapeutic scope of antioxidants for managing HD and other neurological conditions.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K